New MaRS Global Centre Builds on GE's $6 Billion healthymagination Commitment to Improve
Access, Quality and Cost and GE's MOU with Ontario Government
TORONTO, May 31, 2011 /CNW/ - Today, GE opened its first global "Pathology Innovation Centre of Excellence" (PICOE), located at the MaRS Discovery District in Toronto. In this new research
and development centre, GE will collaborate with its digital pathology
joint venture, Omnyx™, along with funding partner, HTX (Health
Technology Exchange) and numerous clinical partners to create best
practices and technologies to address current pathology challenges.
This new centre has the potential to revolutionize pathology through
digital innovation. Developing products and processes to increase
patient access to skilled pathologists and to empower pathologists with
tools for more efficient, consistent and accurate examination will be
part of the Centre's focus. By tackling issues of cost, quality and
access of pathology services, the Centre is a core component of GE's
healthymagination business strategy. PICOE builds on a Memorandum of
Understanding (MOU) GE signed with the Ontario government in September
2009 to partner and invest long-term within the province.
GE was attracted to Canada because of the expertise and leadership in
digital pathology adoption in centres like Toronto, as well as the
innovative and collaborative culture. MaRS, a leading innovation
centre, serves as an ideal hub for PICOE given its close proximity to
hospitals, highly skilled pathologists, clinical partners and academia.
The new 2,150-square foot centre includes a digital lab where GE will
conduct training, research and development on Omnyx™ IDP (Integrated
Digital Pathology) platform with clinical collaborators. The lab will
house Omnyx's Pathologist and Histology Workstations, as well as
showcase Omnyx's VL series of high-resolution scanners which will
digitize glass slides.
"PICOE's opening is one way GE is investing and innovating with
collaborators to find new ways to address costs, quality and access
barriers to health for individuals and entire healthcare systems," said
Peter Robertson, Vice President & General Manager of GE Healthcare
Canada. "PICOE will create 15 new highly skilled jobs over the next
three years and give pathologists and clinical partners the resources
to accelerate research and development and testing for new digital
pathology solutions. "
"PICOE is an integral component of our strategy to ensure customers get
the full value of their adoption of Digital Pathology," said Gene
Cartwright, CEO of Omnyx. "We are excited to be part of the vibrant
community surrounding the MaRS Discovery District in Toronto."
"We are absolutely delighted to welcome GE Healthcare to the MaRS
Centre. GE is a global innovation leader, and their arrival at MaRS
affirms their commitment to Ontario and to furthering collaboration
with the outstanding science, tech and social innovators in our
ecosystem. This decision is timely, as a number of health innovation
initiatives in the MaRS community are showing exceptional promise,
offering unique opportunities for collaboration and partnership," said
Dr. Ilse Treurnicht, CEO of MaRS Discovery District.
"The opening of PICOE and hiring of staff are exciting initial
milestones, and we look forward to watching the Centre develop
quickly," said John Soloninka, President and CEO of HTX - the Health
Technology Exchange. "We have already received enquiries about how
companies can collaborate with PICOE, and how other Multinational
Enterprises can take advantage of the innovation ecosystem that GE has
seen in Ontario. This is a very positive step for Ontario medtech
commercialization, and one HTX is very pleased to support."
"The opening of this Centre of Excellence is great news for Ontario;
digital pathology will help reduce costs and give Ontarians faster and
more accurate diagnoses, regardless of their location, " said Glen
Murray, Minister of Research and Innovation. "PICOE will also help
position Ontario as one of the world's top imaging clusters, attracting
new companies and creating high-paying jobs."
QUICK FACTS- Challenges Facing Pathology Today
There is a shortage of pathologists in Canada. Today, there is a need
for an additional 370 pathologists. By 2020, the country will need an
additional 820 pathologists.
An aging and growing population has been linked to a rising incidence of
cancer increasing the need for timely access to pathology.
GE (NYSE: GE) is an advanced technology, services and finance company
taking on the world's toughest challenges. Dedicated to innovation in
energy, health, transportation and infrastructure, GE operates in more
than 100 countries and employs about 300,000 people worldwide. For more
information, visit the company's Web site at www.ge.com. In Canada, GE has operations across the country, including major
manufacturing, sales and service locations with 8,000 employees. Follow
GE Canada on Twitter at: http://twitter.com/GE_Canada and YouTube at http://www.youtube.com/user/GECanada
ABOUT GE HEALTHCARE:
GE Healthcare provides transformational medical technologies and
services that are shaping a new age of patient care. Our broad
expertise in medical imaging and information technologies, medical
diagnostics, patient monitoring systems, drug discovery,
biopharmaceutical manufacturing technologies, performance
improvement and performance solutions services help our customers to
deliver better care to more people around the world at a lower cost. In
addition, we partner with healthcare leaders, striving to leverage the
global policy change necessary to implement a successful shift to
sustainable healthcare systems.
Our "healthymagination" vision for the future invites the world to join
us on our journey as we continuously develop innovations focused on
reducing costs, increasing access and improving quality around the
world. Headquartered in the United Kingdom, GE Healthcare is a unit of
General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees
are committed to serving healthcare professionals and their patients in
more than 100 countries. For more information about GE Healthcare,
visit our website at www.gehealthcare.com.
For our latest news, please visit http://newsroom.gehealthcare.com
Healthymagination is GE's $6 billion commitment that was launched in May
2009. Our "healthymagination" vision for the future invites the world
to join us on our journey as we continuously develop innovations
focused on reducing costs, increasing access and improving quality and
efficiency around the world. For more information, visit: www.healthymagination.com
Omnyx, LLC is a joint venture of GE Healthcare and The University of
Pittsburgh Medical Center with locations in Pittsburgh, PA and
Piscataway, NJ. The company is developing an enterprise platform to
transform the scope of pathology to an all-digital workflow. Omnyx will
offer an enterprise software platform for image management, workflow
automation, image analysis algorithms and system integration along with
its high speed whole-slide scanners. Close collaboration with
pathologists at UPMC and other institutions along with their
relationship with GE Healthcare allows Omnyx to focus its innovation on
the needs of anatomic pathologists worldwide. Omnyx digital pathology
products are currently in development and have not yet been cleared by
the US FDA or licensed by Health Canada.
SOURCE GE Healthcare
For further information:
Communications Manager, GE Healthcare